|
|
|
Insider
Information: |
Clarke John K |
Relationship: |
Director |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
97,811 |
|
Indirect Shares
|
2,446,095 |
|
|
Direct
Value |
$6,063,405 |
|
|
Indirect Value
|
$8,780,096 |
|
|
Total
Shares |
2,543,906 |
|
|
Total
Value |
$14,843,501 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Momenta Pharmaceuticals Inc |
MNTA |
Director |
2015-05-12 |
69,123 |
2006-11-20 |
0 |
Premium* |
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2018-05-31 |
8,891 |
2014-05-21 |
8,891 |
Premium* |
|
Visicu Inc |
EICU |
Director, 10% Owner |
2008-02-20 |
0 |
2008-02-20 |
0 |
Premium* |
|
Verastem, Inc. |
VSTM |
Director |
2012-02-01 |
0 |
2013-06-12 |
2,329,121 |
Premium* |
|
aTyr Pharma Inc |
LIFE |
Director |
2023-04-26 |
19,797 |
2021-05-21 |
108,083 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
43 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2004-05-27 |
4 |
B |
$0.00 |
$0 |
I/I |
232,500 |
232,500 |
2.17 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2004-06-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,859,368 |
2,091,868 |
|
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2014-05-21 |
4 |
AS |
$52.95 |
$1,882,979 |
D/D |
(35,000) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2014-05-21 |
4 |
OE |
$7.08 |
$456,850 |
D/D |
35,000 |
35,000 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2018-05-31 |
4 |
AS |
$99.38 |
$1,504,678 |
D/D |
(15,000) |
8,891 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2018-05-31 |
4 |
OE |
$27.28 |
$409,200 |
D/D |
15,000 |
23,891 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2015-05-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,572 |
|
- |
|
LIFE |
aTyr Pharma Inc |
Former 10% Owner |
|
2015-05-12 |
4 |
A |
$0.00 |
$0 |
I/I |
1,758,158 |
1,758,158 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Former 10% Owner |
|
2015-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
92,306 |
104,878 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2020-08-26 |
4 |
S |
$4.30 |
$9,451 |
I/I |
(2,200) |
123,383 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2020-08-27 |
4 |
S |
$4.09 |
$22,250 |
I/I |
(5,440) |
117,943 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2020-08-28 |
4 |
S |
$4.00 |
$400 |
I/I |
(100) |
117,843 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2020-09-02 |
4 |
S |
$4.01 |
$29,113 |
I/I |
(7,260) |
110,583 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2021-05-21 |
4 |
S |
$4.34 |
$10,850 |
I/I |
(2,500) |
108,083 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2023-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
19,797 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2004-06-25 |
4 |
B |
$6.50 |
$448,500 |
I/I |
69,000 |
2,170,286 |
2.1 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2004-06-25 |
4 |
A |
$0.00 |
$0 |
I/I |
2,101,286 |
2,170,286 |
|
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2005-02-28 |
4 |
B |
$7.80 |
$97,500 |
D/D |
12,500 |
36,500 |
2.39 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2005-03-01 |
4 |
B |
$8.15 |
$195,600 |
D/D |
24,000 |
36,500 |
2.39 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2005-03-07 |
4 |
B |
$8.51 |
$212,700 |
D/D |
25,000 |
72,300 |
2.39 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2005-03-08 |
4 |
B |
$8.54 |
$92,250 |
D/D |
10,800 |
72,300 |
2.39 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2005-07-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,693,450) |
476,836 |
|
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2005-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
7,197 |
79,497 |
|
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2005-12-15 |
5 |
GD |
$0.00 |
$0 |
D/D |
4,400 |
77,123 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2006-11-20 |
5 |
A |
$0.00 |
$0 |
D/D |
2,026 |
77,123 |
0 |
- |
|
43 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|